We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ELAN market cap is 5.16B. The company's latest EPS is USD 0.6834 and P/E is 15.26.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.04B | 1.21B | 1.18B | 1.03B | 1.02B |
| Operating Income | -5M | 87M | 35M | 54M | 6M |
| Net Income | -141M | 32M | -50M | 364M | -8M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.28B | 4.77B | 4.41B | 4.42B | 4.44B |
| Operating Income | -696.1M | -48M | 201M | -817M | 182M |
| Net Income | -560.1M | -472M | -78M | -1.23B | 338M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.36B | 14.02B | 13.76B | 13.28B | 12.61B |
| Total Liabilities | 8.14B | 7.96B | 7.82B | 6.76B | 6.52B |
| Total Equity | 6.22B | 6.06B | 5.94B | 6.52B | 6.1B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.69B | 16.48B | 15.49B | 14.36B | 12.61B |
| Total Liabilities | 9.22B | 8.95B | 8.2B | 8.14B | 6.52B |
| Total Equity | 8.48B | 7.54B | 7.29B | 6.22B | 6.1B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 271M | 2M | 202M | 364M | 541M |
| Investing | -169M | 37M | 4M | 1.25B | 1.16B |
| Financing | -83M | -27M | -120M | -1.46B | -1.49B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41M | 483M | 452M | 271M | 541M |
| Investing | -4.78B | -530M | -179M | -169M | 1.16B |
| Financing | 4.95B | 210M | -549M | -83M | -1.49B |
| Market Cap | 5.16B |
| Price to Earnings Ratio | 15.26 |
| Price to Sales Ratio | 1.16 |
| Price to Cash Ratio | 11.02 |
| Price to Book Ratio | 0.85 |
| Dividend Yield | - |
| Shares Outstanding | 494.61M |
| Average Volume (1 week) | 4.13M |
| Average Volume (1 Month) | 5.15M |
| 52 Week Change | -34.26% |
| 52 Week High | 18.69 |
| 52 Week Low | 10.03 |
| Spread (Intraday) | 1 (8.99%) |
| Company Name | Elanco Animal Health Incorporated |
| Address |
135 north pennsylvania street indianapolis, indiana 46204 |
| Website | https://www.elanco.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
